HealthCare Partners Expands Relationship with AposHealth® to Bring an Innovative, Non-Invasive Treatment for Knee Osteoarthritis to Members Through a New Delivery Model NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- HealthCare Partners (HCP) today announced an expansion of its partnership with AposHealth® to bring an innovative, non-invasive treatment for knee...

AposHealth Awarded Research Grant to Support Rebuilding Efforts in the United Kingdom LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- AposHealth®, a global leader in the identification and treatment of gait-related conditions known for its clinically proven, non-invasive treatment for knee...

Healthfirst New York Formalizes Coverage of an Innovative Therapy Called AposTherapy® Designed for Use in Orthopedic Conditions NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Developed by experts in orthopedics and sports medicine, the AposTherapy® foot-worn device is FDA-cleared for treating knee osteoarthritis and a non-FDA...